Dermatomycoses Drug Market - Global Outlook and Forecast 2021-2027

Code: RW00014560513
Market Monitor Global
Oct-2021
Life Sciences
105 Pages

This report contains market size and forecasts of Dermatomycoses Drug in global, including the following market information:
Global Dermatomycoses Drug Market Revenue, 2016-2021, 2022-2027, ($ millions)
Global Dermatomycoses Drug Market Sales, 2016-2021, 2022-2027, (K Units)
Global top five Dermatomycoses Drug companies in 2020 (%)
The global Dermatomycoses Drug market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Dermatomycoses Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Dermatomycoses Drug Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Dermatomycoses Drug Market Segment Percentages, By Type, 2020 (%)
BB-2603
Clotrimazole
Dapaconazole
Others

Global Dermatomycoses Drug Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Dermatomycoses Drug Market Segment Percentages, By Application, 2020 (%)
Hospital
Clinic
Others

Global Dermatomycoses Drug Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions) & (K Units)
Global Dermatomycoses Drug Market Segment Percentages, By Region and Country, 2020 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa

Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Dermatomycoses Drug revenues in global market, 2016-2021 (Estimated), ($ millions)
Key companies Dermatomycoses Drug revenues share in global market, 2020 (%)
Key companies Dermatomycoses Drug sales in global market, 2016-2021 (Estimated), (K Units)
Key companies Dermatomycoses Drug sales share in global market, 2020 (%)
Further, the report presents profiles of competitors in the market, key players include:
Anacor Pharmaceuticals Inc
Biolab Farmaceutica Ltda
Blueberry Therapeutics Ltd
Daewoong Pharmaceutical Co Ltd
Dermala Inc
Helix BioMedix Inc
Novan Inc
Sol-Gel Technologies Ltd
TGV-Laboratories
Viamet Pharmaceuticals Inc
Vyome Biosciences Pvt Ltd

Table of Contents

1 Introduction to Research & Analysis Reports
1.1 Dermatomycoses Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Dermatomycoses Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Dermatomycoses Drug Overall Market Size
2.1 Global Dermatomycoses Drug Market Size: 2021 VS 2027
2.2 Global Dermatomycoses Drug Revenue, Prospects & Forecasts: 2016-2027
2.3 Global Dermatomycoses Drug Sales (Consumption): 2016-2027
3 Company Landscape
3.1 Top Dermatomycoses Drug Players in Global Market
3.2 Top Global Dermatomycoses Drug Companies Ranked by Revenue
3.3 Global Dermatomycoses Drug Revenue by Companies
3.4 Global Dermatomycoses Drug Sales by Companies
3.5 Global Dermatomycoses Drug Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Dermatomycoses Drug Companies in Global Market, by Revenue in 2020
3.7 Global Manufacturers Dermatomycoses Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Dermatomycoses Drug Players in Global Market
3.8.1 List of Global Tier 1 Dermatomycoses Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Dermatomycoses Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Global Dermatomycoses Drug Market Size Markets, 2021 & 2027
4.1.2 BB-2603
4.1.3 Clotrimazole
4.1.4 Dapaconazole
4.1.5 Others
4.2 By Type - Global Dermatomycoses Drug Revenue & Forecasts
4.2.1 By Type - Global Dermatomycoses Drug Revenue, 2016-2021
4.2.2 By Type - Global Dermatomycoses Drug Revenue, 2022-2027
4.2.3 By Type - Global Dermatomycoses Drug Revenue Market Share, 2016-2027
4.3 By Type - Global Dermatomycoses Drug Sales & Forecasts
4.3.1 By Type - Global Dermatomycoses Drug Sales, 2016-2021
4.3.2 By Type - Global Dermatomycoses Drug Sales, 2022-2027
4.3.3 By Type - Global Dermatomycoses Drug Sales Market Share, 2016-2027
4.4 By Type - Global Dermatomycoses Drug Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Dermatomycoses Drug Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 Others
5.2 By Application - Global Dermatomycoses Drug Revenue & Forecasts
5.2.1 By Application - Global Dermatomycoses Drug Revenue, 2016-2021
5.2.2 By Application - Global Dermatomycoses Drug Revenue, 2022-2027
5.2.3 By Application - Global Dermatomycoses Drug Revenue Market Share, 2016-2027
5.3 By Application - Global Dermatomycoses Drug Sales & Forecasts
5.3.1 By Application - Global Dermatomycoses Drug Sales, 2016-2021
5.3.2 By Application - Global Dermatomycoses Drug Sales, 2022-2027
5.3.3 By Application - Global Dermatomycoses Drug Sales Market Share, 2016-2027
5.4 By Application - Global Dermatomycoses Drug Price (Manufacturers Selling Prices), 2016-2027
6 Sights by Region
6.1 By Region - Global Dermatomycoses Drug Market Size, 2021 & 2027
6.2 By Region - Global Dermatomycoses Drug Revenue & Forecasts
6.2.1 By Region - Global Dermatomycoses Drug Revenue, 2016-2021
6.2.2 By Region - Global Dermatomycoses Drug Revenue, 2022-2027
6.2.3 By Region - Global Dermatomycoses Drug Revenue Market Share, 2016-2027
6.3 By Region - Global Dermatomycoses Drug Sales & Forecasts
6.3.1 By Region - Global Dermatomycoses Drug Sales, 2016-2021
6.3.2 By Region - Global Dermatomycoses Drug Sales, 2022-2027
6.3.3 By Region - Global Dermatomycoses Drug Sales Market Share, 2016-2027
6.4 North America
6.4.1 By Country - North America Dermatomycoses Drug Revenue, 2016-2027
6.4.2 By Country - North America Dermatomycoses Drug Sales, 2016-2027
6.4.3 US Dermatomycoses Drug Market Size, 2016-2027
6.4.4 Canada Dermatomycoses Drug Market Size, 2016-2027
6.4.5 Mexico Dermatomycoses Drug Market Size, 2016-2027
6.5 Europe
6.5.1 By Country - Europe Dermatomycoses Drug Revenue, 2016-2027
6.5.2 By Country - Europe Dermatomycoses Drug Sales, 2016-2027
6.5.3 Germany Dermatomycoses Drug Market Size, 2016-2027
6.5.4 France Dermatomycoses Drug Market Size, 2016-2027
6.5.5 U.K. Dermatomycoses Drug Market Size, 2016-2027
6.5.6 Italy Dermatomycoses Drug Market Size, 2016-2027
6.5.7 Russia Dermatomycoses Drug Market Size, 2016-2027
6.5.8 Nordic Countries Dermatomycoses Drug Market Size, 2016-2027
6.5.9 Benelux Dermatomycoses Drug Market Size, 2016-2027
6.6 Asia
6.6.1 By Region - Asia Dermatomycoses Drug Revenue, 2016-2027
6.6.2 By Region - Asia Dermatomycoses Drug Sales, 2016-2027
6.6.3 China Dermatomycoses Drug Market Size, 2016-2027
6.6.4 Japan Dermatomycoses Drug Market Size, 2016-2027
6.6.5 South Korea Dermatomycoses Drug Market Size, 2016-2027
6.6.6 Southeast Asia Dermatomycoses Drug Market Size, 2016-2027
6.6.7 India Dermatomycoses Drug Market Size, 2016-2027
6.7 South America
6.7.1 By Country - South America Dermatomycoses Drug Revenue, 2016-2027
6.7.2 By Country - South America Dermatomycoses Drug Sales, 2016-2027
6.7.3 Brazil Dermatomycoses Drug Market Size, 2016-2027
6.7.4 Argentina Dermatomycoses Drug Market Size, 2016-2027
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Dermatomycoses Drug Revenue, 2016-2027
6.8.2 By Country - Middle East & Africa Dermatomycoses Drug Sales, 2016-2027
6.8.3 Turkey Dermatomycoses Drug Market Size, 2016-2027
6.8.4 Israel Dermatomycoses Drug Market Size, 2016-2027
6.8.5 Saudi Arabia Dermatomycoses Drug Market Size, 2016-2027
6.8.6 UAE Dermatomycoses Drug Market Size, 2016-2027
7 Manufacturers & Brands Profiles
7.1 Anacor Pharmaceuticals Inc
7.1.1 Anacor Pharmaceuticals Inc Corporate Summary
7.1.2 Anacor Pharmaceuticals Inc Business Overview
7.1.3 Anacor Pharmaceuticals Inc Dermatomycoses Drug Major Product Offerings
7.1.4 Anacor Pharmaceuticals Inc Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.1.5 Anacor Pharmaceuticals Inc Key News
7.2 Biolab Farmaceutica Ltda
7.2.1 Biolab Farmaceutica Ltda Corporate Summary
7.2.2 Biolab Farmaceutica Ltda Business Overview
7.2.3 Biolab Farmaceutica Ltda Dermatomycoses Drug Major Product Offerings
7.2.4 Biolab Farmaceutica Ltda Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.2.5 Biolab Farmaceutica Ltda Key News
7.3 Blueberry Therapeutics Ltd
7.3.1 Blueberry Therapeutics Ltd Corporate Summary
7.3.2 Blueberry Therapeutics Ltd Business Overview
7.3.3 Blueberry Therapeutics Ltd Dermatomycoses Drug Major Product Offerings
7.3.4 Blueberry Therapeutics Ltd Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.3.5 Blueberry Therapeutics Ltd Key News
7.4 Daewoong Pharmaceutical Co Ltd
7.4.1 Daewoong Pharmaceutical Co Ltd Corporate Summary
7.4.2 Daewoong Pharmaceutical Co Ltd Business Overview
7.4.3 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Major Product Offerings
7.4.4 Daewoong Pharmaceutical Co Ltd Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.4.5 Daewoong Pharmaceutical Co Ltd Key News
7.5 Dermala Inc
7.5.1 Dermala Inc Corporate Summary
7.5.2 Dermala Inc Business Overview
7.5.3 Dermala Inc Dermatomycoses Drug Major Product Offerings
7.5.4 Dermala Inc Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.5.5 Dermala Inc Key News
7.6 Helix BioMedix Inc
7.6.1 Helix BioMedix Inc Corporate Summary
7.6.2 Helix BioMedix Inc Business Overview
7.6.3 Helix BioMedix Inc Dermatomycoses Drug Major Product Offerings
7.6.4 Helix BioMedix Inc Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.6.5 Helix BioMedix Inc Key News
7.7 Novan Inc
7.7.1 Novan Inc Corporate Summary
7.7.2 Novan Inc Business Overview
7.7.3 Novan Inc Dermatomycoses Drug Major Product Offerings
7.4.4 Novan Inc Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.7.5 Novan Inc Key News
7.8 Sol-Gel Technologies Ltd
7.8.1 Sol-Gel Technologies Ltd Corporate Summary
7.8.2 Sol-Gel Technologies Ltd Business Overview
7.8.3 Sol-Gel Technologies Ltd Dermatomycoses Drug Major Product Offerings
7.8.4 Sol-Gel Technologies Ltd Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.8.5 Sol-Gel Technologies Ltd Key News
7.9 TGV-Laboratories
7.9.1 TGV-Laboratories Corporate Summary
7.9.2 TGV-Laboratories Business Overview
7.9.3 TGV-Laboratories Dermatomycoses Drug Major Product Offerings
7.9.4 TGV-Laboratories Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.9.5 TGV-Laboratories Key News
7.10 Viamet Pharmaceuticals Inc
7.10.1 Viamet Pharmaceuticals Inc Corporate Summary
7.10.2 Viamet Pharmaceuticals Inc Business Overview
7.10.3 Viamet Pharmaceuticals Inc Dermatomycoses Drug Major Product Offerings
7.10.4 Viamet Pharmaceuticals Inc Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.10.5 Viamet Pharmaceuticals Inc Key News
7.11 Vyome Biosciences Pvt Ltd
7.11.1 Vyome Biosciences Pvt Ltd Corporate Summary
7.11.2 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Business Overview
7.11.3 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Major Product Offerings
7.11.4 Vyome Biosciences Pvt Ltd Dermatomycoses Drug Sales and Revenue in Global (2016-2021)
7.11.5 Vyome Biosciences Pvt Ltd Key News
8 Global Dermatomycoses Drug Production Capacity, Analysis
8.1 Global Dermatomycoses Drug Production Capacity, 2016-2027
8.2 Dermatomycoses Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Dermatomycoses Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Dermatomycoses Drug Supply Chain Analysis
10.1 Dermatomycoses Drug Industry Value Chain
10.2 Dermatomycoses Drug Upstream Market
10.3 Dermatomycoses Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Dermatomycoses Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Dermatomycoses Drug in Global Market
Table 2. Top Dermatomycoses Drug Players in Global Market, Ranking by Revenue (2019)
Table 3. Global Dermatomycoses Drug Revenue by Companies, (US$, Mn), 2016-2021
Table 4. Global Dermatomycoses Drug Revenue Share by Companies, 2016-2021
Table 5. Global Dermatomycoses Drug Sales by Companies, (K Units), 2016-2021
Table 6. Global Dermatomycoses Drug Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Dermatomycoses Drug Price (2016-2021) & (USD/Unit)
Table 8. Global Manufacturers Dermatomycoses Drug Product Type
Table 9. List of Global Tier 1 Dermatomycoses Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Dermatomycoses Drug Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type

Anacor Pharmaceuticals Inc
Biolab Farmaceutica Ltda
Blueberry Therapeutics Ltd
Daewoong Pharmaceutical Co Ltd
Dermala Inc
Helix BioMedix Inc
Novan Inc
Sol-Gel Technologies Ltd
TGV-Laboratories
Viamet Pharmaceuticals Inc
Vyome Biosciences Pvt Ltd

First Name *

Last Name

Country *

E-mail *

Contact No *

Company Name*

Job Title*

Comments

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Have a Question?

EMAIL US

RELATED PRODUCTS

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

View All New Reports

Global Freckle-removing Medical and Beau.. The global market for Freckle-removing Medical and Beauty Eq..

Global Wall Mounted Sinks Market Growth .. The sink is a trough-shaped appliance used to receive kitche..

Global Peripheral Imaging Catheter Marke.. The Peripheral Imaging Catheter's unique design provides exc..

Global Hemostatic Valves and Accessories.. Haemostatic valve prevents blood reflux when a catheter is i..

Global Liver Cancer Treatment Drug Marke.. The global market for Liver Cancer Treatment Drug is estimat..

Global Hypertensive Heart Disease Drug M.. The global market for Hypertensive Heart Disease Drug is est..

Global Urinary Incontinence Drug Market .. The global market for Urinary Incontinence Drug is estimated..

Global Pet Antibiotic Market Growth 2022.. The global market for Pet Antibiotic is estimated to increas..

Global Hemorrhagic Disease Detection Mar.. The global market for Hemorrhagic Disease Detection is estim..

Global Cell Dissociation Solution Market.. The global market for Cell Dissociation Solution is estimate..

Global Cell Detachment and Dissociation .. The global market for Cell Detachment and Dissociation Solut..

Global Cell Detachment Solution Market G.. The global market for Cell Detachment Solution is estimated ..

CUSTOM RESEARCH

ReportsWeb has an extensive coverage of industry reports, company reports and country reports accross all industries.

LEARN MORE